1020 related articles for article (PubMed ID: 2997287)
1. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
2. Elevated allogeneic cytotoxic T lymphocyte activity in peripheral blood leukocytes of homosexual men.
Tung KS; Koster F; Bernstein DC; Kriebel PW; Payne SM; Shearer GM
J Immunol; 1985 Nov; 135(5):3163-71. PubMed ID: 3876378
[TBL] [Abstract][Full Text] [Related]
3. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population.
Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S
Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064
[TBL] [Abstract][Full Text] [Related]
5. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
[TBL] [Abstract][Full Text] [Related]
6. Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years.
Frazer IH; Mackay IR; Crapper RM; Jones B; Gust ID; Sarngadharan MG; Campbell DC; Ungar B
Q J Med; 1986 Oct; 61(234):921-33. PubMed ID: 3498182
[TBL] [Abstract][Full Text] [Related]
7. Relation of HTLV-III seropositivity and lymphadenopathy.
Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
[TBL] [Abstract][Full Text] [Related]
8. Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome.
Shearer GM; Payne SM; Joseph LJ; Biddison WE
J Clin Invest; 1984 Aug; 74(2):496-506. PubMed ID: 6611354
[TBL] [Abstract][Full Text] [Related]
9. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832
[TBL] [Abstract][Full Text] [Related]
10. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
13. Virologic studies in a case of transfusion-associated AIDS.
Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P
N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
15. Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.
Pedersen C; Kolby P; Sindrup JH; Arendrup M; Wulf HC; Gaub J; Gerstoft J; Lindhardt BO
Dan Med Bull; 1986 Oct; 33(5):270-2. PubMed ID: 2946558
[TBL] [Abstract][Full Text] [Related]
16. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex.
Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP
Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878
[TBL] [Abstract][Full Text] [Related]
17. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC
Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083
[TBL] [Abstract][Full Text] [Related]
18. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
19. Immunological findings associated with HTLV-III antibody positivity.
Antonen J
Ann Clin Res; 1985; 17(2):81-5. PubMed ID: 2994542
[TBL] [Abstract][Full Text] [Related]
20. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
